Literature DB >> 21371563

Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice.

Josien Levenga1, Femke M S de Vrij, Ronald A M Buijsen, Tracy Li, Ingeborg M Nieuwenhuizen, Andreea Pop, Ben A Oostra, Rob Willemsen.   

Abstract

Fragile X syndrome (FXS) is the most common inherited form of mental retardation and is caused by the lack of fragile X mental retardation protein (FMRP). In the brain, spine abnormalities have been reported in both patients with FXS and Fmr1 knockout mice. This altered spine morphology has been linked to disturbed synaptic transmission related to altered signaling in the excitatory metabotropic glutamate receptor 5 (mGluR5) pathway. We investigated hippocampal protrusion morphology in adult Fmr1 knockout mice. Our results show a hippocampal CA1-specific altered protrusion phenotype, which was absent in the CA3 region of the hippocampus. This suggests a subregion-specific function of FMRP in synaptic plasticity in the brain.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21371563     DOI: 10.1016/j.nlm.2011.02.009

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  28 in total

Review 1.  The trouble with spines in fragile X syndrome: density, maturity and plasticity.

Authors:  C X He; C Portera-Cailliau
Journal:  Neuroscience       Date:  2012-04-20       Impact factor: 3.590

2.  Genealogical correspondence of a forebrain centre implies an executive brain in the protostome-deuterostome bilaterian ancestor.

Authors:  Gabriella H Wolff; Nicholas J Strausfeld
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-01-05       Impact factor: 6.237

Review 3.  Moving Toward Integrative, Multidimensional Research in Modern Psychiatry: Lessons Learned From Fragile X Syndrome.

Authors:  Lawrence K Fung; Allan L Reiss
Journal:  Biol Psychiatry       Date:  2015-12-18       Impact factor: 13.382

4.  Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation.

Authors:  Robert F Berman; Karl D Murray; Gloria Arque; Michael R Hunsaker; H Jürgen Wenzel
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

Review 5.  Autism spectrum disorder-associated genes and the development of dentate granule cells.

Authors:  Hidenori Ito; Rika Morishita; Koh-Ichi Nagata
Journal:  Med Mol Morphol       Date:  2017-05-22       Impact factor: 2.309

6.  Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome.

Authors:  Safdar Jawaid; Grahame J Kidd; Jing Wang; Carrie Swetlik; Ranjan Dutta; Bruce D Trapp
Journal:  Glia       Date:  2017-12-23       Impact factor: 7.452

7.  Early social enrichment rescues adult behavioral and brain abnormalities in a mouse model of fragile X syndrome.

Authors:  Diego Oddi; Enejda Subashi; Silvia Middei; Luigi Bellocchio; Valerie Lemaire-Mayo; Manuel Guzmán; Wim E Crusio; Francesca R D'Amato; Susanna Pietropaolo
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

8.  Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of Fragile X Syndrome.

Authors:  Julie C Lauterborn; Matiar Jafari; Alex H Babayan; Christine M Gall
Journal:  Cereb Cortex       Date:  2013-09-17       Impact factor: 5.357

9.  Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant.

Authors:  Andreea S Pop; Josien Levenga; Celine E F de Esch; Ronald A M Buijsen; Ingeborg M Nieuwenhuizen; Tracy Li; Aaron Isaacs; Fabrizio Gasparini; Ben A Oostra; Rob Willemsen
Journal:  Psychopharmacology (Berl)       Date:  2012-12-21       Impact factor: 4.530

10.  Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice.

Authors:  Da Shi; Su Xu; Jaylyn Waddell; Susanna Scafidi; Steven Roys; Rao P Gullapalli; Mary C McKenna
Journal:  J Neurochem       Date:  2012-11-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.